The Use of an "Anal-Tape" in Patients With Fecal Incontinence
Primary Purpose
Fecal Incontinence
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Anal Tape
Sponsored by
About this trial
This is an interventional treatment trial for Fecal Incontinence
Eligibility Criteria
Inclusion Criteria:
- >18 years old
- Fecal incontinence for more than 6 months
- Willing to participate
- Understand the study procedures
- Is able to apply and remove the "anal tape" without significant assistance of others.
- Have done sigmoidsocopy or colonoscopy and anal manometry within five year of screening visit
Exclusion Criteria:
- Advanced full thickness rectal prolapse.
- Injured, inflamed or any significant disease in the peri-anal skin.
- Allergy to any component of the device, either known or developed during testing in the screening visit.
- Moderate to severe proctitis of any etiology.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
No Intervention
Experimental
Arm Label
Off treatment
Treatment period
Arm Description
2 week period without intervention
2 week period with intervention
Outcomes
Primary Outcome Measures
Any Improvment in the Fecal Incontince Quality of Life Scale (FIQoLs)
The FIQoL is a validated, condition-specific tool that evaluates quality of life (QoL) in patients with fecal incontinence (FI) it consisting of 29 questions, subdivided into four domains: Lifestyle, Coping/Behavior, Depression/Self-perception, and Embarrassment. Item 1, general health, is graded from 1 "excellent" to 5 "poor" and is reversely scored. Items 2 to 28 are graded on a 4-point Likert-scale (1 = lower QoL). Item 29, FI specific depression, is graded from 1 "extremely so" to 6 "not at all." The average score for each domain is calculated separately and is calculated only if half or more of the items in the particular domain have been answered. Scales range from 1 to 5, with a 1 indicating a lower quality of life. Each domain or subscale is reported separately (Range 1 to 5), a total score including all four domains is not calculated.
Secondary Outcome Measures
A 50% Reduction in the Number of Episodes of FI Per Week
Number of pateints with reduction of more than 50% in the absolute number of FI events during each week of the study
Mean Wexner Score
The Wexner Scale is a measure of frequency and severity of anal incontinence. It comprises five items, three regarding frequency of involuntary passage of gas, liquid, or solid stool, frequency of pad wearing, and frequency of lifestyle alteration, scored in a 5-point Likert-scale (never=0, rarely=1, sometimes=2, usually=3, always=4). A sum of all scores from 0 to 20 is calculated with higher scores meaning more severe incontince.
Mean Redction in Wexner Scale Compared to Baseline
The Wexner Scale is a measure of frequency and severity of anal incontinence. It comprises five items, three regarding frequency of involuntary passage of gas, liquid, or solid stool, frequency of pad wearing, and frequency of lifestyle alteration, scored in a 5-point Likert-scale (never=0, rarely=1, sometimes=2, usually=3, always=4). A sum of all scores from 0 to 20 is calculated with higher scores meaning more severe incontince.
General Satisfaction
General satisfaction with the device was assessed using a standard 100 mm visual analog scale. Patients were asked to grade their satisfaction with the device between 0 and 100 by drawing a perpendicular line in the 100 mm visual analog scale. Then the distance in mm was measured in mm from 0 to the perpendicular line and the score was calculated. Higher scores meaning better satisfaction.
Willingness of the Patient to Continue Using the Anal Tape After the Study.
Willingness of the patient to continue using the device was assessed using a standard 100 mm visual analog scale. Patients were asked to grade their willingness to use the device in the future between 0 and 100 by drawing a perpendicular line in the 100 mm visual analog scale. Then the distance in mm was measured in mm from 0 to the perpendicular line and the score was calculated. Higher scores meaning better satisfaction.
Full Information
NCT ID
NCT02989545
First Posted
December 7, 2016
Last Updated
April 1, 2020
Sponsor
Shaare Zedek Medical Center
1. Study Identification
Unique Protocol Identification Number
NCT02989545
Brief Title
The Use of an "Anal-Tape" in Patients With Fecal Incontinence
Official Title
The Use of an "Anal-Tape" in Patients With Fecal Incontinence
Study Type
Interventional
2. Study Status
Record Verification Date
April 2020
Overall Recruitment Status
Completed
Study Start Date
December 2016 (undefined)
Primary Completion Date
December 2018 (Actual)
Study Completion Date
December 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Shaare Zedek Medical Center
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Fecal incontinence (FI), defined as the involuntary passage of stool for more than 3 months and is a devastating disease. The negative impact on quality of life has been consistently demonstrated. The prevalence of FI is probably underestimated in most studies. Currently conservative treatment is only modestly effective and surgical treatment is complex and expensive with less than optimal efficacy.
The investigators developed an "anal tape" using a commercially available elastic band with a special adhesive that is approved for use in the skin. A special design of the tape can be applied to the skin surrounding the anus providing support and additional pressure forces to the anal sphincter.
This is a 4 week, prospective, non blinded, cross-over study to explore the efficacy and safety of this device in patients with FI. The primary endpoint will be improvement in quality of life.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Fecal Incontinence
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
20 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Off treatment
Arm Type
No Intervention
Arm Description
2 week period without intervention
Arm Title
Treatment period
Arm Type
Experimental
Arm Description
2 week period with intervention
Intervention Type
Device
Intervention Name(s)
Anal Tape
Primary Outcome Measure Information:
Title
Any Improvment in the Fecal Incontince Quality of Life Scale (FIQoLs)
Description
The FIQoL is a validated, condition-specific tool that evaluates quality of life (QoL) in patients with fecal incontinence (FI) it consisting of 29 questions, subdivided into four domains: Lifestyle, Coping/Behavior, Depression/Self-perception, and Embarrassment. Item 1, general health, is graded from 1 "excellent" to 5 "poor" and is reversely scored. Items 2 to 28 are graded on a 4-point Likert-scale (1 = lower QoL). Item 29, FI specific depression, is graded from 1 "extremely so" to 6 "not at all." The average score for each domain is calculated separately and is calculated only if half or more of the items in the particular domain have been answered. Scales range from 1 to 5, with a 1 indicating a lower quality of life. Each domain or subscale is reported separately (Range 1 to 5), a total score including all four domains is not calculated.
Time Frame
2 weeks
Secondary Outcome Measure Information:
Title
A 50% Reduction in the Number of Episodes of FI Per Week
Description
Number of pateints with reduction of more than 50% in the absolute number of FI events during each week of the study
Time Frame
4 weeks
Title
Mean Wexner Score
Description
The Wexner Scale is a measure of frequency and severity of anal incontinence. It comprises five items, three regarding frequency of involuntary passage of gas, liquid, or solid stool, frequency of pad wearing, and frequency of lifestyle alteration, scored in a 5-point Likert-scale (never=0, rarely=1, sometimes=2, usually=3, always=4). A sum of all scores from 0 to 20 is calculated with higher scores meaning more severe incontince.
Time Frame
2 weeks
Title
Mean Redction in Wexner Scale Compared to Baseline
Description
The Wexner Scale is a measure of frequency and severity of anal incontinence. It comprises five items, three regarding frequency of involuntary passage of gas, liquid, or solid stool, frequency of pad wearing, and frequency of lifestyle alteration, scored in a 5-point Likert-scale (never=0, rarely=1, sometimes=2, usually=3, always=4). A sum of all scores from 0 to 20 is calculated with higher scores meaning more severe incontince.
Time Frame
2 weeks
Title
General Satisfaction
Description
General satisfaction with the device was assessed using a standard 100 mm visual analog scale. Patients were asked to grade their satisfaction with the device between 0 and 100 by drawing a perpendicular line in the 100 mm visual analog scale. Then the distance in mm was measured in mm from 0 to the perpendicular line and the score was calculated. Higher scores meaning better satisfaction.
Time Frame
2 weeks
Title
Willingness of the Patient to Continue Using the Anal Tape After the Study.
Description
Willingness of the patient to continue using the device was assessed using a standard 100 mm visual analog scale. Patients were asked to grade their willingness to use the device in the future between 0 and 100 by drawing a perpendicular line in the 100 mm visual analog scale. Then the distance in mm was measured in mm from 0 to the perpendicular line and the score was calculated. Higher scores meaning better satisfaction.
Time Frame
4 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
>18 years old
Fecal incontinence for more than 6 months
Willing to participate
Understand the study procedures
Is able to apply and remove the "anal tape" without significant assistance of others.
Have done sigmoidsocopy or colonoscopy and anal manometry within five year of screening visit
Exclusion Criteria:
Advanced full thickness rectal prolapse.
Injured, inflamed or any significant disease in the peri-anal skin.
Allergy to any component of the device, either known or developed during testing in the screening visit.
Moderate to severe proctitis of any etiology.
12. IPD Sharing Statement
Citations:
PubMed Identifier
35039916
Citation
Livovsky DM, Koslowsky B, Goldin E, Lysy J. External kinesiology tape for improvement in fecal incontinence symptom bother in women: a pilot study. Int Urogynecol J. 2022 Oct;33(10):2859-2868. doi: 10.1007/s00192-021-05050-z. Epub 2022 Jan 18.
Results Reference
derived
Learn more about this trial
The Use of an "Anal-Tape" in Patients With Fecal Incontinence
We'll reach out to this number within 24 hrs